Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Giovanni Triolo; Andre Beaulieu; Josef Rovensky; Andre Beaulieu; Rieke Alten; Cesar Ramos-Remus; Thasia Woodworth; Josef S Smolen; Andrea Rubbert-Roth; Emma Alecock

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Giovanni Triolo, Andre Beaulieu, Josef Rovensky, Andre Beaulieu, Rieke Alten, Cesar Ramos-Remus, Thasia Woodworth, Josef S Smolen, Andrea Rubbert-Roth, Emma Alecock

Research output: Contribution to journal › Article › peer-review

1176 Citations (Scopus)

Original language	English
Pages (from-to)	987-997
Journal	The Lancet
Volume	371
Publication status	Published - 2008

All Science Journal Classification (ASJC) codes

General Medicine

Cite this

@article{340862a1cfac48e587bdeaa74650a445,

title = "Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.",

author = "Giovanni Triolo and Andre Beaulieu and Josef Rovensky and Andre Beaulieu and Rieke Alten and Cesar Ramos-Remus and Thasia Woodworth and Smolen, {Josef S} and Andrea Rubbert-Roth and Emma Alecock",

year = "2008",

language = "English",

volume = "371",

pages = "987--997",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

AU - Triolo, Giovanni

AU - Beaulieu, Andre

AU - Rovensky, Josef

AU - Beaulieu, Andre

AU - Alten, Rieke

AU - Ramos-Remus, Cesar

AU - Woodworth, Thasia

AU - Smolen, Josef S

AU - Rubbert-Roth, Andrea

AU - Alecock, Emma

PY - 2008

Y1 - 2008

UR - http://hdl.handle.net/10447/33723

M3 - Article

VL - 371

SP - 987

EP - 997

JO - The Lancet

JF - The Lancet

SN - 0140-6736

ER -

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

All Science Journal Classification (ASJC) codes

Other files and links

Cite this